In many patients with atrial fibrillation (AF), AF ablation and left atrial appendage closure (LAA closure) can be combined during the same minimally invasive procedure.
This combined strategy may allow simultaneous treatment of:
– atrial fibrillation symptoms
– stroke prevention
– bleeding prevention
– reduction of lifelong anticoagulation burden
Modern pulsed field ablation (PFA) technologies increasingly simplify combined procedures and may allow rapid recovery and short hospital stay.
OPTION trial and evolving treatment strategies
Recent studies such as OPTION have significantly changed the discussion regarding long-term treatment strategies after AF ablation.
Traditionally, many patients remained on lifelong anticoagulation after AF ablation, even after apparently successful rhythm control.
At CARDIOVASCULAR GLOBAL, we believe that combined AF ablation and LAA closure represents a comprehensive long-term strategy integrating rhythm control, stroke prevention, bleeding prevention, and reduction of lifelong anticoagulation burden.
We believe that stroke prevention and bleeding prevention should be addressed proactively during AF ablation rather than postponed until future complications occur.
Treatment decisions remain individualized and are based on anatomy, stroke risk, bleeding risk, frailty, lifestyle, patient preference, and long-term treatment goals.
Patients we frequently evaluate
We frequently evaluate patients including:
– patients seeking alternatives to lifelong anticoagulation
– younger or active patients concerned about long-term anticoagulation
– patients with elevated bleeding risk
– patients planning AF ablation and stroke prevention simultaneously
– patients with lifestyle or occupational concerns related to anticoagulation
Our approach
At CARDIOVASCULAR GLOBAL, combined AF ablation and LAA closure procedures are individualized and based on careful evaluation of each patient’s specific situation.